Has Scott Rosen, MD received payments from drug or device companies?

Yes. Drug and device makers reported $291 in general payments to Scott Rosen, MD across 11 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Scott Rosen, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Scott Rosen, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Scott Rosen, MD

Internal Medicine · Southaven, MSNPI 1952665655

Payments from drug & device makers

$291in general payments, 2019–2025

Across 11 payments — averaging $26.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$121
AbbVie$38
Vifor Pharma, Inc.$33
Johnson & Johnson$32
AstraZeneca$31
Gilead$19
plus $17 from 1 others

What the payments were for

Food & beverage$291100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	2	$121
AbbVie	2	$38
Vifor Pharma, Inc.	2	$33
Johnson & Johnson	2	$32
AstraZeneca	1	$31
Gilead	1	$19
Bioventus LLC	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ENTRESTO$103

How this compares

$291 in reported general payments places this provider in the 40th percentile of 846 internal medicine providers in Mississippi.

See all internal medicine providers in Mississippi →

Medicare billing

Part B allowed, 2024

$94,629

Medicare patients

341

Services billed

931

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Pantoprazole Sodium	16	$87
Hydralazine Hcl	13	$78
Atorvastatin Calcium	12	$56
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	11	$52
Furosemide	17	$41
Amlodipine Besylate	15	$33
Carvedilol	12	$30
Metoprolol Tartrate	11	$24

Paid to pharmacies, not to this prescriber.

Other internal medicine in Southaven

James HallBrookhaven$4.8M
Bob HutchinsJackson$4.6M
Sidney GortonBelzoni$571K
David PendleyGulfport$336K
Sarah KerutJackson$319K
Gabriel HernandezJackson$196K
Kelly WilkinsonJackson$183K
Magdy Gorgi-MikhailBiloxi$157K
Christina BarlowJackson$129K
Arnold JacksonHattiesburg$121K

See the full list for Mississippi →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →